Mandate

Vinge advises Main Capital and Aunetic in connection with the acquisition of Qnister

Vinge has advised Aunetic, a leading governance software specialist, in connection with the acquisition of Qnister AB (“Qnister”). The strategic acquisition enhances Aunetic’s product portfolio and strengthens its presence in the Swedish software compliance market.

Founded in 2017, Qnister is as a SaaS-company specialising in compliance software solutions, providing GDPR and whistleblowing solutions as well as services in sanctions screening and contract management to small and medium-sized enterprises in the private sector and to customers within the public sector.

The acquisition aligns with Aunetic’s goal to expand its compliance software suite and market reach, positioning Aunetic as a leading governance software group in Europe.

Vinge’s team mainly consisted of Filip Öhrner, Linus Adolfsson, Jonatan Stentorp (M&A), Emil Lindwall, Gulestan Ali (Employment), Carla Håkansson (Commercial Agreements & GDPR), Ian Jonson (IP) and Gabriella Balbo (Transaction Support Coordinator).

Related

Vinge advised Precise Biometrics

Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026